FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma

Kafashzadeh D, Kachru R. A Cautionary Tale: Urticaria and Angioedema As Presenting Signs of Lymphoproliferative Disorders. Cureus. 2026 Apr 9;18(4):e106738. doi: 10.7759/cureus.106738. PMID: 42109948; PMCID:[...]

Riemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud[...]

Chen HC, Bang MF, Wang HH, Shpargel KB, Kohn LA, Sailer D, Zhang S, McCarthy EC, Seyedsadr M, Stevens S, Pham CLH, Zhou Z, Yin[...]